Valiant effort by Valeant, Q3 beats estimates
Share

Valiant effort by Valeant, Q3 beats estimates

Michael Pearson, Valeant Pharmaceuticals CEO, breaks down the company's quarterly numbers and provides an outlook on future growth.
01:03
Mon, Oct 20 20147:21 AM EDT